The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome

被引：2
|
作者：
Youkhana, Kimberley [1 ]
Heiling, Hilary [2 ]
Deal, Allison [2 ]
Moll, Stephan [1 ]
机构：
[1] Univ N Carolina, Sch Med, Dept Med, Div Hematol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biostat, Chapel Hill, NC 27599 USA
来源：
TH OPEN | 2023年 / 07卷 / 03期
关键词：
MANIFESTATIONS; ANTIBODIES;
D O I：
10.1055/s-0043-1770784
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e191 / e194
页数：4
相关论文
共 50 条
  • [21] Antiphospholipid syndrome development after rituximab treatment
    Faillace, Cesar
    de Carvalho, Jozelio Freire
    JOINT BONE SPINE, 2012, 79 (02) : 200 - 201
  • [22] Effective treatment of antiphospholipid syndrome with plasmapheresis and rituximab
    Tsagalis, G.
    Psimenou, E.
    Nakopoulou, L.
    Laggouranis, A.
    HIPPOKRATIA, 2010, 14 (03) : 215 - 216
  • [23] HIGH ANTIPHOSPHOLIPID ANTIBODY TITERS ARE ASSOCIATED WITH ADVERSE PREGNANCY OUTCOME IN WOMEN WITH ANTIPHOSPHOLIPID ANTIBODY SYNDROME
    Simchen, Michal J.
    Pauzner, Rachel
    Rofe, Guy
    Schiff, Eyal
    Dulitzki, Mordechai
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (06) : S138 - S138
  • [24] Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome
    Sciascia, S.
    Naretto, C.
    Rossi, D.
    Bazzan, M.
    Roccatello, D.
    LUPUS, 2011, 20 (10) : 1106 - 1108
  • [25] Antiphospholipid antibodies and coronary atherosclerosis: the antiphospholipid syndrome patients
    Plazak, W.
    Padjas, A.
    Celinska-Lowenhoff, M.
    Iwaniec, G.
    Swadzba, J.
    Luberda, T.
    Musial, J.
    Podolec, P.
    EUROPEAN HEART JOURNAL, 2013, 34 : 1013 - 1013
  • [26] Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab
    Berman, Horacio
    Rodriguez-Pinto, Ignasi
    Cervera, Ricard
    Morel, Nathalie
    Costedoat-Chalumeau, Nathalie
    Erkan, Doruk
    Shoenfeld, Yehuda
    Espinosa, Gerard
    AUTOIMMUNITY REVIEWS, 2013, 12 (11) : 1085 - 1090
  • [27] RITUXIMAB IN CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME: A POTENTIAL THERAPEUTIC OPTION
    Berman, H.
    Rodriguez-Pinto, I.
    Espinosa, G.
    Cervera, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 259 - 260
  • [28] 'Cure' of life-threatening antiphospholipid syndrome with rituximab
    Anandacoomarasamy, A.
    Gibson, J.
    McGill, N.
    INTERNAL MEDICINE JOURNAL, 2006, 36 (07) : 474 - U10
  • [29] ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME
    ASHERSON, RA
    CERVERA, R
    GHARAVI, AE
    ANNALES DE MEDECINE INTERNE, 1993, 144 (05): : 367 - 376
  • [30] Antiphospholipid Antibody and Antiphospholipid Syndrome
    吴竞生
    血栓与止血学, 2008, 14 (06) : 243 - 245
12345